JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.09B |
| 2 |
Broadcom
AVGO
|
+$1.03B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$970M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$877M |
| 5 |
Verizon
VZ
|
+$875M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.37B |
| 3 |
TWX
Time Warner Inc
TWX
|
+$764M |
| 4 |
IBM
IBM
|
+$737M |
| 5 |
Philip Morris
PM
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Financials | 14% |
| 3 | Technology | 12.71% |
| 4 | Healthcare | 9.7% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Mueller Water Products
MWA
$3.42B
| $1.93M | ﹤0.01% |
164,399
+7,402
| +5% | +$82.7K |
2013 Q2
20 quarters
|
|
3302
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.32B
| $1.92M | ﹤0.01% |
27,976
-683
| -2% | -$46.1K |
2013 Q2
20 quarters
|
|
3303
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.34B
| $1.91M | ﹤0.01% |
29,794
-144
| -0.5% | -$9.63K |
2017 Q4
2 quarters
|
|
3304
Sixth Street Specialty
TSLX
$1.73B
| $1.91M | ﹤0.01% |
106,375
+103,354
| +3,421% | +$1.89M |
2015 Q2
12 quarters
|
|
|
BPMC
3305
CALL
DELISTED
Blueprint Medicines
BPMC
| $1.9M | ﹤0.01% |
30,000
+3,000
| +11% | +$239K |
2018 Q1
1 quarter
|
|
|
BPMC
3306
PUT
DELISTED
Blueprint Medicines
BPMC
| $1.9M | ﹤0.01% |
30,000
+3,000
| +11% | +$239K |
2018 Q1
1 quarter
|
|
3307
Flotek Industries
FTK
$1.12B
| $1.9M | ﹤0.01% |
98,101
+79,699
| +433% | +$1.98M |
2015 Q4
10 quarters
|
|
3308
Ramaco Resources Class A
METC
$531M
| $1.9M | ﹤0.01% |
281,566
+280,305
| +22,229% | +$2M |
2017 Q4
2 quarters
|
|
3309
OFS Capital
OFS
$48M
| $1.9M | ﹤0.01% |
165,402
-35,785
| -18% | -$400K |
2017 Q2
4 quarters
|
|
3310
8x8 Inc
EGHT
$337M
| $1.89M | ﹤0.01% |
94,423
-155,936
| -62% | -$3.11M |
2015 Q1
13 quarters
|
|
|
LDL
3311
DELISTED
Lydall, Inc.
LDL
| $1.89M | ﹤0.01% |
43,366
+5,749
| +15% | +$252K |
2013 Q2
20 quarters
|
|
|
MODV
3312
DELISTED
ModivCare
MODV
| $1.89M | ﹤0.01% |
23,995
+6,023
| +34% | +$452K |
2017 Q4
2 quarters
|
|
|
UCFC
3313
DELISTED
United Community Financial Corp
UCFC
| $1.89M | ﹤0.01% |
171,496
-7,598
| -4% | -$79.8K |
2014 Q4
14 quarters
|
|
3314
Glaukos
GKOS
$9.85B
| $1.88M | ﹤0.01% |
46,218
+37,299
| +418% | +$1.33M |
2016 Q1
9 quarters
|
|
|
LGF.B
3315
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.87M | ﹤0.01% |
79,772
+18,420
| +30% | +$428K |
2016 Q4
6 quarters
|
|
3316
Tanger
SKT
$3.99B
| $1.86M | ﹤0.01% |
79,385
+20,046
| +34% | +$441K |
2013 Q2
20 quarters
|
|
3317
CALL
Coherus Oncology
CHRS
$182M
| $1.86M | ﹤0.01% |
+133,000
| New | +$1.9M |
2018 Q2
0 quarters
|
|
3318
iShares US Treasury Bond ETF
GOVT
$41.4B
| $1.86M | ﹤0.01% |
75,605
-477
| -0.6% | -$11.7K |
2015 Q4
10 quarters
|
|
3319
HealthStream
HSTM
$938M
| $1.86M | ﹤0.01% |
68,075
+33,708
| +98% | +$894K |
2017 Q3
3 quarters
|
|
3320
Ligand Pharmaceuticals
LGND
$6.11B
| $1.86M | ﹤0.01% |
14,379
-17,893
| -55% | -$2M |
2015 Q4
10 quarters
|
|
|
IMDZ
3321
DELISTED
Immune Design Corp.
IMDZ
| $1.86M | ﹤0.01% |
407,844
-435,083
| -52% | -$1.73M |
2014 Q3
15 quarters
|
|
3322
Builders FirstSource
BLDR
$6.29B
| $1.85M | ﹤0.01% |
101,100
-365,354
| -78% | -$6.98M |
2017 Q1
5 quarters
|
|
|
AET
3323
PUT
DELISTED
Aetna Inc
AET
| $1.83M | ﹤0.01% |
10,000
| – | – |
2017 Q1
5 quarters
|
|
3324
CALL
Lockheed Martin
LMT
$115B
| $1.83M | ﹤0.01% |
6,200
+2,700
| +77% | +$871K |
2016 Q4
6 quarters
|
|
|
NSU
3325
DELISTED
Nevsun Resources Ltd.
NSU
| $1.83M | ﹤0.01% |
+527,943
| New | +$1.62M |
2018 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2018 Portfolio in Review
As of Q2 2018, JP Morgan Chase held 5,918 positions worth $486B, up 4.2% from $467B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2018 filing shows 539 new, 2,430 increased, 2,080 reduced and 346 closed positions. Its largest new stake was Evergy: 3,598,208 shares worth $202M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2018 buy was Evergy: 3,598,208 shares worth $202M.
- JP Morgan Chase added most to Salesforce in Q2 2018, an estimated $1.09B increase.
- JP Morgan Chase's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.58B.
- JP Morgan Chase fully exited Time Warner Inc in Q2 2018, selling an estimated $764M.
- JP Morgan Chase's ten largest holdings make up 17% of its $486B portfolio in Q2 2018.
- JP Morgan Chase opened 539 new positions and closed 346 in Q2 2018.
- JP Morgan Chase's portfolio value rose 4.2% quarter-over-quarter to $486B.
Based on JP Morgan Chase's 13F filing for Q2 2018, filed 14 Aug 2018.